{"meta":{"query_hash":"773fd77ec749","filters":{"venue":"American Journal of Blood Research"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/773fd77ec749","api":"https://metacan.xera.ac/api/v1/cohort?venue=American+Journal+of+Blood+Research"},"results":[{"id":"W4411938444","doi":"10.62347/coly8536","title":"Acute myolysis in patients on tyrosine kinase inhibitor therapy for chronic myeloid leukemia","year":2025,"lang":"en","type":"article","venue":"American Journal of Blood Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Myeloid leukemia; Tyrosine-kinase inhibitor; Tyrosine kinase; Internal medicine; Oncology; Cancer research; Receptor; Cancer","score_opus":0.020225638861801228,"score_gpt":0.3526977058180067,"score_spread":0.33247206695620546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411938444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99514246,0.0011084422,0.00018473183,0.0002336245,0.000020732625,0.000026615684,0.00004269495,0.000011966622,0.003228749],"genre_scores_gemma":[0.9993549,0.00025479,0.000065680375,0.000075544674,0.00003258051,0.0000031272975,0.000034097775,9.744904e-7,0.00017837406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998055,0.000030811017,0.00002738701,0.000027540807,0.000041120376,0.00006761138],"domain_scores_gemma":[0.99959,0.00010403252,0.00015827734,0.000016226699,0.000027755223,0.00010380379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014548114,0.0002324848,0.0002767,0.0006164205,0.00058012654,0.00032993846,0.00015702413,0.0005081626,0.0020358786],"category_scores_gemma":[0.0008543192,0.00011176067,0.00020357639,0.00040248618,0.00035380773,0.00030232072,0.00034615476,0.00047257147,0.00020311939],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023772841,0.0000731729,0.91729355,0.00004780197,0.000018407029,0.07158923,0.00027876408,0.000084991734,0.0028809796,0.000080258105,0.00034524623,0.007069941],"study_design_scores_gemma":[0.000027065515,0.00049420795,0.81169736,0.00004349482,0.000032682132,0.18435188,0.00063787296,0.00024000533,0.0011405712,0.00016513598,0.0011567794,0.000012962098],"about_ca_topic_score_codex":0.00097291515,"about_ca_topic_score_gemma":0.0014237704,"teacher_disagreement_score":0.0020358786,"about_ca_system_score_codex":0.00022911448,"about_ca_system_score_gemma":0.00023501164,"threshold_uncertainty_score":0.0068107247},"labels":[],"label_agreement":null}]}